BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 18, 2013
View Archived Issues
Clinical data for AMP-224 presented at AACR meeting
Read More
Polymorphisms in NPY and IL1B genes identified as risk factors for vitiligo
Read More
FDA approves Sitavig for labial herpes
Read More
Innovative 3D renal tissue model developed to investigate human disease and toxicity
Read More
IMCgp-100 well tolerated in patients with advanced melanoma
Read More
VAL-201 shows promise in animal models of prostate and breast cancer
Read More
Achillion begins phase II HCV study of sovaprevir and ACH-3102
Read More
Allergan receives complete response letter for Levadex NDA
Read More
Ablynx presents in vitro and in vivo data for novel anti-c-Met Nanobody
Read More
Merck & Co. synthesizes new FSH-R antagonists for gynecological disorders
Read More
Roche discloses novel eIF4E inhibitors for cancer
Read More
New JAK1/JAK2 inhibitors divulged by Merck & Co.
Read More
Boehringer Ingelheim patents new DPPI inhibitors
Read More
Bayer prepares new Mnk1 inhibitors for hyperproliferative diseases
Read More
Researchers at GlaxoSmithKline synthesize new mTOR inhibitors
Read More
FDA grants Charleston Laboratories' request for pre-IND meeting
Read More
Galapagos expands phase IIb trial of GLPG-0634 in rheumatoid arthritis
Read More
Clinical trial application submitted to RAC for TT-034
Read More
Eisai receives marketing authorization in Japan for vascular embolization device Dc Bead
Read More
Nymox's candidate for BPH shows promising sexual function profile in new study
Read More
Collegium Pharmaceutical completes study on Oxycodone DETERx
Read More
Neuralstem receives FDA approval to conduct phase II stem cell trial for ALS
Read More
Taisho seeks Japanese approval of luseogliflozin for type 2 diabetes
Read More
Omeros files orphan drug application for OMS-721
Read More
Santarus and Pharming report submission of Ruconest BLA to FDA
Read More
FDA advisory committee votes in favor of Breo Ellipta for COPD
Read More